Y Takada

Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group.

Satoshi Kudoh, Yasuhiro Fujiwara, Y Takada et al. · Journal of Clinical Oncology · 1998 · 170 citations

Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients

Masahide Fukudo, Ikuko Yano, Satohiro Masuda et al. · Clinical Pharmacology & Therapeutics · 2005 · 88 citations

Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer

Yuichiro Ohe, Shunichi Negoro, Kunihiko Matsui et al. · Annals of Oncology · 2005 · 87 citations · Full text

Medicine, Metronomic Therapy, Pathology +7

Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)

Koji Takeda, Shunichi Negoro, Tomohide Tamura et al. · Annals of Oncology · 2009 · 67 citations

Non-small-cell Lung Cancer, Medicine, Metronomic Therapy +10

294 A randomized phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with mitomycin (M), vindesine (V), and cisplatin (P) in unresectable stage III non-small cell lung cancer (NSCLC): Preliminary analysis

Y Takada, Kiyoyuki Furuse, M. Fukuoka et al. · Lung Cancer · 1997 · 63 citations

Radiation Medicine, Radiation Therapy, Medicine +7